Search results
Results from the WOW.Com Content Network
The lawsuits come after a spate of attacks on Waymo cars in San Francisco, ranging from safety activists placing traffic cones on the cars' hoods to disable them to a laughing, cheering mob who ...
Waymo said it is already providing 150,000 trips per week in Phoenix, Los Angeles, San Francisco, and Austin. Uber, which relies on human drivers for its ride-hailing, could possibly be threatened ...
Waymo said in March it was beginning to offer free driverless robotaxi services to select members of the public in Los Angeles after receiving approval from a state agency to start its ride ...
According to a February 2017 civil lawsuit filed by Waymo officially known as Waymo v. Uber (Levandowski was not a defendant in the case), [44] Levandowski allegedly "downloaded 9.7 GB of Waymo's confidential files and trade secrets, including blueprints, design files, and testing documentation" [45] [46] before resigning to found Otto.
The truce resolved a lawsuit alleging former Uber CEO Travis Kalanick conspired with former Google engineer Anthony Levandowski to steal Waymo’s self-driving car technology. Levandowski later pled guilty to criminal charges that arose from the civil lawsuit, but avoided an 18-month prison sentence in January 2021 when he was pardoned by ...
The study also found that the Waymo driver “significantly” reduced property damage claims. Beyond safety, Panigrahi said there is a growing use case for autonomous vehicles to reduce ...
In the latest bad news for Uber, the judge presiding over its trade secrets lawsuit with Google self-driving car unit Waymo has asked federal prosecutors to investigate the case. Reuters and ...
The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...